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A cDNA has been isolated from  human  hippocampus 
that  appears to encode  a  novel  Na+-dependent,  Cl--inde- 
pendent,  neutral  amino  acid  transporter. The putative 
protein,  designated SA", is 529 amino acids long  and 
exhibits significant amino acid sequence identity (39- 
44%) with mammalian  L-glutamate transporters.  Expres- 
sion of  SATT  cDNA in HeLa cells induced  stereospecific 
uptake of L-serine,  L-alanine,  and  L-threonine  that  was 
not inhibited by excess (3 mM) 2-(methylamino)-isobutyr- 
ic acid, a specific substrate  for the System A amino  acid 
transporter. SATT expression in HeLa cells did  not in- 
duce the transport of radiolabeled L-cysteine, L-gluta- 
mate,  or related dicarboxylates.  Northern  blot  hybrid- 
ization  revealed high levels of SATT mRNA in human 
skeletal  muscle,  pancreas,  and  brain,  intermediate lev- 
els  in heart, and  low levels in liver,  placenta,  lung,  and 
kidney. SATT transport  characteristics  are  similar to the 
Na+-dependent neutral amino acid transport activity 
designated  System ASC, but  important  differences  are 
noted.  These  include: 1) SATT's apparent  low  expression 
in ASC-containing tissues such as liver or placenta; 2) 
the lack of mutual inhibition  between  serine  and cys- 
teine; and 3) the lack of trans-stimulation. SATT may 
represent  one of multiple activities that  exhibit  System 
ASC-like  transport  characteristics in diverse tissues and 
cell lines. 
Carrier-mediated  amino  acid  transport has evolved to  main- 
tain  transmembrane  fluxes of amino  acids for cellular  nutrition 
and  metabolism.  In  eukaryotic  cells, a large  number of distinct 
amino  acid  transport  systems  have  been  distinguished  based 
on  differences  in  substrate specificity, kinetic  properties,  and 
ionic  dependence (1, 2). Our  knowledge of the structural  prop- 
erties of amino  acid  transporters is limited.  However,  recent 
advances  in  the  cloning of amino  acid  transporters  have  begun 
to  provide  insights  into  the  molecular  basis of carrier-mediated 
amino  acid  transport. A  cDNA clone, SAAT1, has recently  been 
described that exhibits  structural  and  sequence  similarity  with 
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the Na+/glucose  cotransporter  family (3) and codes for a Na+- 
dependent  neutral  amino  acid  transporter  with  properties  sim- 
ilar to System A (4). A murine ecotropic retroviral receptor, 
which exhibits sequence homology with yeast permeases for 
histidine  and  arginine, has recently  been  found  to  induce  Na+- 
independent  transport of cationic  amino  acids  with  properties 
similar  to  System  y+ ( 5 ,  6). cDNAs have  also  been  reported for 
putative  regulatory  subunits of a transporter for cystine, di- 
basic, and  neutral  amino  acids  with  properties  similar  to  Sys- 
tem  bo%+,  which  appear  to  contain  single  transmembrane do- 
main and exhibit sequence similarity to glucosidases (7-9). 
Furthermore, cDNAs have  been  isolated  for  plasma  membrane 
transporters for the neurotransmitterimodulator amino  acids, 
including y-aminobutyric acid (10-13), glycine (14, 151, and 
proline (16). Recently  three  distinct,  but  related,  Na+/ 
glutamate cotransporters have been cloned and functionally 
characterized (17-191, which  appear  to  comprise a distinct  gene 
family of membrane  transport  proteins.  An  intriguing  result  to 
emerge from the molecular cloning studies is the extent of 
structural  diversity  within  the  group of amino  acid  transporter 
proteins. 
To explore  the  molecular  diversity  within  the  family of glu- 
tamate  transporters,  we  performed a polymerase chain reac- 
tion  on  human  hippocampal poly(A)+  RNA using  primers cor- 
responding  to a human  expressed  sequence  tag that exhibits 
distant homology to an Escherichia coli glutamate/aspartate 
carrier (20, 21). We identified a novel PCRl  product that was 
used to isolate a full-length cDNA clone from human hippo- 
campus that exhibited 3944% homology with  mammalian  glu- 
tamate transporters. Surprisingly, despite the sequence rela- 
tionship  with  mammalian  glutamate  transporters,  expression 
of this cDNA clone in  HeLa  cells  did  not  induce  L-glutamate 
transport but did induce Na+-dependent neutral amino acid 
uptake  with  several  properties  similar  to  System ASC. How- 
ever, important differences were noted indicating that SATT 
may  represent  only  one of several  molecular  entities that col- 
lectively  account  for  System  ASC-like  transport. 
EXPERIMENTAL PROCEDURES 
PCR and Library Screening-Poly(A)+ mRNA (1 pg) purified from 
human hippocampus was converted to single-stranded cDNA (Super- 
script, Life  Technologies Inc.) using random primers (Pharmacia LKB 
Biotechnology Inc.) and subjected to PCR (22) with Taq  polymerase as 
described by the manufacturer (Perkin-Elmer). Amplification  was con- 
ducted with primers 5'-CCCATTTGCGACAGATTT-3' and 5"CGCCT- 
GCTGCTCCAACA-3' corresponding to a previously described human 
hippocampal expressed sequence tag (21). Amplification conditions 
kilobasek); KRP, Krebs-Ringer-phosphate; MeAIB, 2-(methylamino)- 
The abbreviations used are: PCR, polymerase chain reaction; kb, 
isobutyric acid; bp, base pair(s). 
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were 94 " c  for 1 min,  45 "C for 1 min,  and 72  "C for 1 min,  with  a  final 
extension of 10  min.  The  resulting PCR product  (-0.3  kb)  was cloned 
into  the TA cloning vector (Invitrogen,  San Diego, CA). The cloned insert 
was  used as a  template  in  a PCR containing 0.25 mCi of ["2P]dCTP to 
generate  a probe that  was used to screen 7 x lo5 phage  recombinants 
from a human hippocampal cDNA library in A-zap (Stratagene, La 
Jolla, CA) as  previously  described  (16).  Bluescript  plasmids pBS 
SKII(-)  were  rescued from plaque-purified positives by in vivo excision 
as described by the manufacturer (Stratagene). Overlapping clones 
were  aligned by a  restriction  map  based on the enzymes  BamHI,  XbaI, 
EcoRI, and XhoI. The nucleotide sequence was determined on both 
strands for the two largest clones, 5 and  14, from alkaline  lysate  mini- 
preps of double-stranded DNA,  by dideoxynucleotide chain  termination 
using  Sequenase  (U. S. Biochemical Corp.).  with  synthetic oligonucle- 
otides as sequencing  primers. 
Expression and Pharmacological Studies-Clone 5 contained  a  full- 
length coding sequence  downstream from the  T7  promoter egion of the 
plasmid vector pBS SKII(-). HeLa cells, 150,000-300,000/well in 24- 
well cell culture  plates  (Becton-Dickinson), were infected  with recom- 
binant vaccinia virus  strain VTF,-, (15  plaque-forming  unitdcell) ex- 
pressing  T7 RNA polymerase (231, followed 30  min  later by liposome- 
mediated (3 pglwell; Lipofectin, Life Technologies Inc.)  transfection of 
clone 5 (designated SATT) (1 pg/well). Triplicate  control  transfections of 
a  non-functional  fragment of a rat proline  transporter  (16) cloned into 
pBS SUI(-), done  under  identical  conditions,  were  included on each 
24-well plate to  determine  background  transport. Amino acid transport 
assays were conducted 8-10 h after transfection as described (24). 
Briefly, HeLa cells were incubated twice, for 10 min each, in 2 ml of 
choline Krebs-Ringer-phosphate buffer (choline KRP) followed by a 
1-min  incubation  with  radioactive  amino acid (3  p ~ ;  0.5-1.5 pCi of the 
radiolabeled substrate)  in 250 p1 of uptake buffer (sodium KRP or cho- 
line  KRP)  in  the  presence or absence of unlabeled  amino  acids. MeAIB 
(3 mM) was included in the uptake buffer to eliminate endogenous 
transport  attributable to System  A (1, 2). Following incubation  with  the 
radiolabeled  substrate,  the  uptake  buffer  was  washed  away  (four  rapid 
changes of 2 ml each of ice-cold choline KRP). After washing,  plates 
were  dried  in  a  fume hood, and  the cells were lysed by addition of 0.2 ml 
of 0.2% SDS, 0.2 N NaOH.  Lysate  countsimin were determined for each 
well. For  determination of the specific activity of the  radiolabeled  sub- 
strate, aliquots of the  uptake  mixture were counted.  The  data  are ex- 
pressed as picomoles of radiolabeled  substrate  transported  per well per 
min. 
To examine  the  chloride  dependence of SATT-induced uptake, chlo- 
ride in  the  uptake buffer  was  replaced by thiocyanate or acetate. To test 
for trans-stimulation, transport was assayed immediately after pre- 
loading  HeLa cells (twice for 10  min  each  in choline KRP)  with  3 mM 
L-alanine or 3 mM L-threonine. The cells were  rinsed well prior to con- 
ducting  the  transport  assay. 
Northern  Hybridization Analysis-A 1595-bp  BamHI-XhoI  fragment 
of clone 14 that represented  the coding sequence for the  COOH-termi- 
nal421  amino acids of SATT and 332 bp of the  3'-untranslated  sequence 
was  radiolabeled  with  ["2PldCTP by random  priming (Life Technologies 
Inc.)  and  hybridized to  a  human  multiple  tissue  Northern blot (Clon- 
tech, Palo Alto, CA). Hybridization conditions were 5 x SSPE, 10 x 
Denhardt's  solution, 200 pg/ml sheared  and  denatured  salmon  sperm 
DNA, 35%  formamide,  2%  SDS,  and 1.5 x lo6 c p d m l  radioactive probe 
a t  42 "C for 18 h. After hybridization, the blot was  washed  with  four 
changes of 2 x SSC, 0.05% SDS at room temperature for 10  min  each 
followed by two changes of 0.1 x SSC, 0.1% SDS at 50 "C for 20 min 
each.  The blot was exposed to  x-ray film for 1, 2, or 6  days a t  -80 "C. 
Chromosomal Localization-DNA from somatic cell hybrids for chro- 
mosome mapping  was  obtained from Coriell Cell Repositories  (mapping 
panel 11) (Camden,  NJ).  A 1O-pg aliquot of somatic cell hybrid DNA was 
digested  with Hind111 or EcoRI and  separated on a 0.8% agarose gel. 
The DNA was transferred to nylon filters by Southern blotting and 
hybridized  with the 1595-bp  fragment from clone 14 described for the 
Northern blot (see  above) that  had been  radiolabeled  with PPIdCTP 
using  random  priming.  Hybridization  was  carried  out  using  the 
Quikhyb  hybridization  solution  (Stratagene) at  65 "C for 12 h.  Filters 
were  washed  with 5 x, 1 x, and 0.5 x SSPE and  0.1%  SDS a t  65 "C for 
30 min  each.  Blots  were exposed to Kodak XAR film at  -70 "C for 24-36 
h.  
RESULTS AND DISCUSSION 
Screening of a human  hippocampal cDNA library  with  the 
PCR-generated probe described under "Experimental Proce- 
dures'' yielded 10 overlapping cDNA clones. One full-length 
cDNA, clone 5, was  isolated  and  sequenced  to  identify  an  open 
reading  frame  that  codes  for  529  amino  acids  (Fig.  1).  The first 
ATG present  in  the cDNA was  assigned as the  initiation codon 
on  the  basis  that  it  was 6 base  pairs  downstream  from a single 
in-frame  stop codon. The  3'-untranslated  region of clone 5 ends 
in a poly(A+)  tail  but  lacks a classical  polyadenylation  signal; 
however, the  stretch of six As 27  bases  upstream  from  the start 
of the poly(A)  tail  may  substitute for the canonical AAUAAA. 
Kyte-Doolittle  hydropathy  analysis of the  putative  protein  re- 
veals the presence of multiple  regions (6-10) of significantly 
extended hydrophobicity suitable for the formation of trans- 
membrane  a-helical  domains  (data  not  shown).  Based  on  the 
subjective  nature of hydropathy  analysis,  it  is  not  possible  to 
reliably  predict  the  number of transmembrane  domains.  The 
amino  terminus  does  not  contain a readily  identifiable  signal 
sequence (251, suggesting that this  domain  resides  on  the cy- 
toplasmic face of the membrane. Two canonical sites for N- 
linked  glycosylation are  present  on a presumably  extracellular 
72-amino acid hydrophilic loop between putative transmem- 
brane domains 3 and 4. Interestingly, a large, glycosylated 
hydrophilic extracellular loop is also present between trans- 
membrane domains 3 and 4 in the Na+- and C1"dependent 
neurotransmitter  transporter  family  (26).  As  shown  in  Fig. 1, a 
number of consensus sequences for protein kinase-mediated 
phosphorylation are present in the putative cytoplasmic do- 
mains of the SATT protein. A leucine  heptad  repeat  motif  ex- 
tends  from  the  fourth  transmembrane  domain  through  the sec- 
ond cytosolic loop into  the  fifth  transmembrane  domain  (amino 
acid  residues 223-2581, It remains  to  be  determined  whether 
this  motif  plays a role in  transporter  subunit  oligomerization. 
A search of protein  sequence  data  bases  (April,  1993)  with 
the  putative SATT protein  sequence  revealed  significant  amino 
acid sequence similarity (39-44% amino acid sequence iden- 
tity) with a recently  described  family of mammalian Na+/ 
glutamate cotransporters including GLTP (17), EAACl (19), 
and GLTl (18) (Fig. 2). As shown in Fig. 2, the amino acid 
sequence conservation is approximately %fold higher in the 
carboxyl-terminal  half of these  proteins.  Furthermore, SATT 
and the cloned mammalian glutamate transporters exhibit 
very  similar  hydropathy  profiles  (data  not  shown)  and  share a
conserved putative glycosylation site (SATT residue Amzo3) 
and several putative phosphorylation sites (SATT residues 
SerZ5O, Thr308, and Ser364) (see Fig.  2). Of particular  interest, 
the  sequence  motif AA(I,V,L)FIAQ that is  conserved  through- 
out the evolutionary  diversity of glutamate  transporters  from 
prokaryotes  to  mammals  is  also  conserved  in SATT. In  contrast, 
SATT does  not  share  significant  structural  or  amino  acid  se- 
quence homology with  other  known  ion-coupled  cotransporters. 
When a human  multiple  tissue  Northern blot was  screened 
at high  stringency  with  the SATT probe  (Fig. 31, four  prominent 
transcripts  were  observed, at 4.8, 3.5, 2.8, and  2.2  kb.  Hybrid- 
ization  signals  were  most  prominent  in  skeletal  muscle,  pan- 
creas,  and  brain; a weaker  signal  was  observed  in heart. Only 
low levels of SATT mRNA  were  detected  in liver, kidney,  lung, 
and  placenta. The cDNA whose  sequence  and  expression  char- 
acteristics are described here most likely corresponds to the 
2.2-kilobase  species  seen  in  Fig.  3. 
To examine whether the multiple transcripts observed by 
Northern  blot  analysis  represent he products of related  genes 
or  differentially  processed  species  arising  from a single  primary 
transcript, a probe  identical  to  the  one  employed  in  Northern 
blot analysis  was  used  to  locate  the SATT gene  in  the  human 
genome by Southern hybridization of a DNA panel from SO- 
matic  hybrid cell lines  containing  each of the  human  chromo- 
somes.  The SATT gene  was localized to  human chromosome 2 
in two separate experiments that each employed a different 
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FIG. 1. Nucleotide and deduced 
amino acid sequence of SATE Puta- 
tive  transmembrane  domains  are  under- 
lined. Potential glycosylation and phos- 
phorylation sites have been marked as 
follows: #, tyrosine  kinase  site; A, casein 
kinase I1 site; +, protein  kinase A site; @, 
glycosylation. See  text for details. 
protein  kinase C site; =, site for N-linked 
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CCCGCCTTTCTCGCACCGGCTCCTGCGCCAGGCCCGGAGACCCCCGGGGCGGCTTCCCAGAACCTGCGGACGCAACTGGCCGAC 
CGACCCATTCATTGGGAACCCCGTCTTTTGCCAGAGCCCACGTCCCCTGCCACCTCTAGCTCGGAGCGGCGTGTAGCGCATGGA 
M E  
GAAGAGCAACGAGACCAACGGCTACCTTGACAGCGCTCAGGCGGGGCCTGCGCGGCGGCCCGGAGCTCCGGGACCGCGGCGGGA 
K S N E T N G Y L D S A Q A G P A R R P G A P G P R R D  
# 
CGCACGGCGTTGCGCGGCTTCCTGCGGCGCCAAGCTGGTGGTGCTGCTCACCGTGTCCGGGGTGCTGGCGGGCGCGGGCCTGGGCGC 
A R R C A A S C G A K L V L L T V S G V L A G a G L G A  
GGCGTTGCGCGGGCTCAGCCTGAGCCGCACGCAGGTCACCTACCTGGCCTTCCCCGGCGAGATGCTGCTCCGCATCGTGCGCAT 
A L R G L S L S R T Q V T Y L A F P G E M L L R I V R M  
GATCATCCTGCCGCTGGTGGTCTGCAGCCTGGTGTCGGCGCGCCTCGCTCGATGCCAGCTGCCTCGGGCGTCTGGGCGGCATCG 
I I L P L V V C S L V S A R L A R C Q L P R A S G R H R  
e 
TGTCGCCTACTTTGGCCTCACCACACTGACTGCCTCGGCGCTCGCCGTGGCCTTGGCGTTCATCATCAAGCCAGGATCCGGTGC 
V A Y F G L T T L T A S A L A V A L A F I I K P G S G A  
GCAGACCCTTCAGTCCAGCGACCTGGGGCTGGAGGACTCGGGGCCTCCTCCTGTCCCCAAAGAGACGGTGGACTCTTTCCTCGA 
Q T L Q S S D L G L E D S G P P P V P K E T V D S F L D  
CCTGGCCAGAAACCTGTTTCCCTCCAATCTTGTGGTTGTGGTTGCAGCTTTCCGTACGTATGCAACCGATTATGAAGTCGTGACCCAGAA 
L A R N L F P S N L V V A A F R T Y A T D Y E V V T Q N  
CAGCAGCTCTGGAAATGTAACCCATGAAAAGATCCCCATCCCCATAGGCACTGAGATAGAAGGGATGAACATTTTAGGATTGGTCCTGTT 
S S S G N V T H E K I P I G T E I E G M N I L G L V L F  
TGCTCTGGTGTTAGGAGTGGCCTTARAGAAACTAGGCTAGGCTCCGAAGGAGAAGACCTCATCCGTTTCTTCAATTCCCTCAACGAGGC 
A L V L G V A L K K L G S E G E D L I R F F N S L N E A  
GTCGATGGTGCTGGTGTCCTGGATTATGTGGTACGTACCTGTGGGCATCATGTTCCTTGTTGGAAGCAAGATCGTGG~TGAA 
S M V L V S W I M W Y V P V G I M F L V G S K I V E M K  
1009 A G A C A T C A T C G T G C T G G T G A C C A G C C T G G G G A A A T A C A T C T T G T T C T  
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283 D I I V L V T S L G K Y . I F A S I L G H V I H G G I V L  310 
1093 GCCACTTATTTATTTTGTTTTCACACGRAAAAACCCCATTCAGATTCCTCCTGGGCCTCCTCGCCCCATTTGCGACAGCATTTGC 1176 
311 P L I Y F V F T R K N P F R F L L G L L A P F A T A F A 3 3 8  
~. ~ 
e 
1177 T A C C T G C T C C A G C T C A G C G A C C C T T C C C T C T A T G A T G A A G G A G G A T C A G C A G G T T  1260 
339 T C S S S A T L P S M M K C I E E N N G V D K R I S R F 3 6 6  
t 
1261 TATTCTCCCCATCGGGGCCACCG'PGAACATGGACGGAGCAGCCATCTTCCAGTGTGTGGCCGCGGTGTTCATTGCGCAACTC~ 1344 
367 I L P I G A T V N M D G A A I F Q C Y A A V F I A O L N 3 9 4  
395 N V E L N A G O T F T I L V  
1345 CAACGTAGAGCTCAACGCAGGACAGATTTTCACCATTCTAGTGACTGCCACAGCGTCCAGTGTTGGAGCAGCAGGCGTGCCAGC 1428 
T A T A S S y G A A G V P A 4 2 2  
1429 TCCAGGGGTCCTCACCATTGCCATTATCCTGGAGGCCATTGGGCTGCCTACTCATGACCTGCCTCTGATCCTGGCTGTGGACTG 1512 
423 P G V L T I A I I L E A I G L P T H D L P L I L A V D W 4 5 0  
1513 GATTGTGGACCGGACCACCACGGTGGTGAATGTGGAAGGGGATGCCCTGGGTGCAGGCATTCTCCACCACCTGAATCAGAAGGC 1596 
451 I V D R T T T V V N V E G D A L G A G I L H H L N Q K A 4 7 8  
479 T K K G E Q E L A E V K V E A I P N C K S E E E T S P L 5 0 6  
1597 AACRAAGAAAGGCGAGCAGGAACTTGCTGAGGTGAAAGTGGAAGCCATCCCC~CTGCAAGTCTGAGGAGGAGACATCGCCCCT 1680 
1681 GGTGACACACCAGAACCCCGCTGGCCCCGTGGCCAGTGCCCCAG~CTGG~TCCAAGGAGTCGGAACTGTGATGGGGCTGGGC 1764 
507 V T H Q N P A G P V A S A P E L E S K E S E L . 5 2 9  
e 
1765 TTTGGGCTTGCTGCCAGCAGTATGTCCCACCCTGTTCACCCAGCCGCCAGTCATGGACACAGGGCACTGCCTTGC~CTTTTA 1848 
1849 CCCTCCCAAGCAATGCTTTGGCCCAGTCGCTGGCCTGAGGCTTACCTCTCGGCACTGGCATTGGGCTCCCCAGCCGGAACTGGT 1932 
2017 CCCCTTGAGCTGCCAGGCTCAAGAAATCATGGACTCACAGGGTCCTGTGTGGTTACATCTTGG~TG~GATGTATTTCA 2100 
1933 TACCAAGGACAAGGACACTCTGACATTCGGCTTGATCCATGTCAGGTGCAACTGTGTGTACACCAGGGATCTGTTTGG~C~ 2016 
2101  CTCTCCCCGGTC(A),  2113 
restriction  enzyme  (EcoRI  or Hind1111 for cell line DNA diges- 
tion. EcoRI digestion of control  human  DNA  resulted  in  hybrid- 
ization to a single band; hybridization with HindIII-digested 
DNA  revealed  three  bands  (data  not  shown).  In  each  case,  the 
corresponding  bands  were  seen  only  in  the  human  chromosome 
2 somatic  hybrid cell line.  These  results  are  consistent  with  the 
hypothesis that the multiple SATT transcripts detected by 
Northern  blotting  arise  from a single  gene  (although  additional 
genetic loci on  chromosome 2 cannot  be  excluded).  The biolog- 
ical  significance of SATT transcripts of different  sizes,  includ- 
ing  the  possible  generation of functionally  distinct  isoforms by 
differential RNA processing within the coding sequence, re- 
mains  to  be  determined. 
To determine  the  function of SATT, clone 5 was  expressed  in 
HeLa  cells,  and  uptake  studies  were  conducted.  Initial  studies 
indicated that expression of SATT in  HeLa  cells  did  not  induce 
the  transport of radiolabeled  L-glutamate  or  succinate (at pH 
7.4). Furthermore,  expression of SATT in HeLa cells did not 
induce the transport of radiolabeled  a-ketoglutarate,  pyruvate, 
L-glutamine,  @alanine,  taurine,  L-histidine,  L-ornithine, L-phe- 
nylalanine,  or L-tyrosine. 
HeLa  cells  transfected  with SATT  cDNA consistently  exhib- 
ited a significant  increase  in 3 p~ ~ - [ ~ H l s e r i n e   a n d   ~ - [ ~ H l a l a -  
nine uptake over basal levels (Table I). Preliminary studies 
using  the  System A-specific substrate MeAIB established that 
- 10% of the  basal  transport of alanine  and  serine  in  our  HeLa 
cell population  was  mediated by System A. Subsequently, all 
experiments  were  performed  in  the  presence of 3 mM MeAIB to 
minimize  System  A-mediated  transport of neutral  amino  acids. 
The presence of 3 mM MeAIB did not inhibit SATT-induced 
~-[~Hlserine  uptake.  Transfection-induced  transport  was 
stereospecific; 3 mM o-serine  did  not  significantly  inhibit trans- 
port of 3 mM ~[~Hlse r ine   i n   t r ans fec t ed  ells  (Table  I).  The K,,, 
for ~ - [~Hlse r ine  up take  by SATT-transfected cells was esti- 
mated  to be 56.5 VM by Lineweaver-Burk  analysis of the  de- 
pendence of initial velocity data on substrate concentration 
(data  not  shown).  Removal of Na' from  the  uptake  buffer re- 
duced  basal ~ - [ ~ H l s e r i n e  or ~- [~Hla lan ine   t ranspor t  by 90% in 
untransfected HeLa cells and eliminated the SATT-mediated 
induction in transport (data not shown). However, SATT-in- 
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FIG. 3. Northern hybridization analysis using an SA" probe 
(see "Experimental  Procedures") against mRNA  from multiple 
human tissues. The  main  species  are  the  bands  at 4.8,3.5,2.8, and 2.2 
kb  in  skeletal  muscle,  pancreas,  and  brain. 
duced transport  was  independent of extracellular C1- in the 
assay buffer. Substitution of extracellular C1- with thiocyanate 
or acetate  anions did not inhibit  the SATT-mediated induction 
of ~-[~H]serine  transport (Table I). Excess unlabeled L-threo- 
nine (3 mM) markedly reduced both the basal and SAn"in- 
duced uptake of 3 mM ~-[~Hlser ine  (Table I). 
These  transport properties of SATT are  similar  to System 
ASC, a Na+-dependent  neutral  amino acid transport activity 
that does not transport  N-methylated  substrates  such as 
MeAIB (1, 2, 27). Unlike System A, which can be identified by 
MeAIB uptake, no diagnostic ligands  are available to  distin- 
guish System ASC.  Typically, Na+-dependent, MeAIB-insensi- 
tive uptake of alanine,  serine,  threonine, or cysteine has been 
assigned to System ASC. However, subtle differences in  System 
ASC transport properties have been described in different tis- 
sues. It  is known, for example, that L-cysteine is a better ASC 
substrate  than  threonine  in rat liver but  that  the converse is 
true  in  the  hepatoma cell line HTC (28-31). Indeed, System 
ASC is usually  identified by the exclusion of other  transport 
systems  and  exhibits significant  variability in  substrate spec- 
ificity between tissues (e.g. Refs. 28-31). 
The  transport activity induced by SAW  in  transfected HeLa 
cells, although related, cannot account for all the transport 
properties attributed  to System ASC. Thus,  although L-cysteine 
is a substrate for System ASC (1,2,27,28), expression of  SATT 
in HeLa cells did not induce the  transport of ~-["~S]cysteine 
(Table I). Furthermore, 3 mM unlabeled L-cysteine did not in- 
hibit ~-[~H]serine  uptake  in SATT-transfected cells (Table I). 
Substantial Na+-dependent, MeAIB-insensitive L-cysteine 
transport  is  present  in both skeletal muscle (32)  and pancreas 
(33) (SATT-rich tissues), indicating  additional ASC-like routes 
for L-cysteine uptake  in  these tissues. Previous studies  have 
also observed that increased levels of intracellular  substrates of 
System ASC enhance  the activity of the system, a process called 
trans-stimulation  (see Ref. 27 for review). However, preloading 
of HeLa cells with L-alanine or L-threonine did not stimulate 
SATT-mediated transport  (data not shown). Finally, only low 
levels of SATT mRNA were observed in  tissues such as liver 
and placenta that exhibit  prominent ASC transport activity. 
The  magnitude of SATT-induced transport  in  our expression 
system (1.7-2.0-fold, Table I)  is comparable  with that  seen with 
the System  A cDNA,  SAAT-1, which produced a 2-fold increase 
in MeAIB uptake in transiently transfected COS cells (4). The 
relatively  small magnitude of SATT-induced transport  is most 
likely related  to high background transport of  SA" substrates 
in  HeLa cells. Indeed, a significant proportion of such  basal 
transport  is probably occurring through  the SATT carrier pro- 
tein itself, because we observed substantial levels of SATT 
mRNA (corresponding to the  three most abundant  transcripts 
of 2.2, 3.5, and 4.8 kb seen in Fig. 3) in Northern blots of 
untransfected HeLa cell  mRNA (data not  shown). 
In summary, we have isolated and characterized a cDNA 
clone, SATT, which induces  Na+-dependent, MeAIB-insensitive 
uptake of serine,  threonine,  and  alanine  in transfected HeLa 
cells. These SATT transport  characteristics  are  similar to the 
Na+-dependent neutral amino acid transport activity desig- 
nated System ASC. However, several  properties of the cloned 
SATT transporter, as expressed in  the HeLa cell, distinguish it 
from the generically described System ASC. These include: 1) 
the lack of L-cysteine transport;  2)  the lack of trans-stimulation; 
and 3) the low levels of expression of  SATT in ASC-rich tissues 
such as liver and placenta. Thus, SA" is likely to  represent 
one of multiple activities  that collectively account for System 
ASC-mediated amino acid uptake  in diverse tissues  and cell 
lines.  Interestingly, SATT does not share significant structural 
or amino acid sequence homology with SAAT-1, the Na+-de- 
pendent, MeAIB-sensitive "System A" neutral amino acid 
transporter (4), even though both transporters  share several 
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TABLE I
Dansport  characteristics of SATT expressed in HeLa cells 
measurements.  Transported  substrates  were  present  at 3 PM in  Na-KRP  uptake buffer and 3 mM MeAIB (see  "Experimental  Procedures"). Cell 
Uptake  is  expressed as  pmol of substrate  transported  per  min  in one well of a 24-well culture  plate.  Each  value  is  the  mean 2 S.D. of triplicate 
count  per well was  identical for a given set of control uersus transfected  uptake  measurements  but  varied from 150,000 t o  300,000 among  different 
of transport  varied  approximately  according to  estimated cell density. 
sets of experiments.  The  percent  increase  in  transport  seen  with SATT transfection  was  consistent for a  given  substrate;  the  absolute  magnitude 
Uptake 
Substrate  Increase 
Control SATT-transfected 
pmollwelllmin 9 
[3HJ~-Serine 3.9 5 0.48  6.8 2 0.07  74 
C3H]~-Alanine 3.2 5 0.05  5.4 2 0.18  69 
13H]~-Serine  in  presence of 3 mM L-threonine 0.73 k 0.11 0.92 * 0.12  26 
13H]~-Serine  in  presence of 3 mM D-serine 3.7 f 0.46  6.2 t 0.36  68 
[3H]~-Serine  in absence of chloride  (replaced by 5.4"  9.4 .c 0.52  72 
 cysteine^ 4.4 t 1.0 4.0 f 2.8 -10 
L3H1~-Serine in presence of 3 mM L-cysteineb 4.2 * 0.09  8.5 5 0.81 102 
acetate) 
" Duplicate  measurements  were  made 15.7 and 5.0 pmol/well/min). 
Experiment  performed  in  the  presence of 0.1 mM dithiothreitol  in  uptake buffer. 
common substrates  and Na' dependence (1,2,  27). Previously, 
a putative "Na+-binding domain" has been proposed for a bac- 
terial Na+/glutamate cotransporter based on a short, loosely 
defined region of amino acid sequence similarity present in 
several Na+-dependent  symporters  (26, 34), including SAATl 
(4); this sequence motif is not present in SATT. Although SATT 
does not  transport L-glutamate or related dicarboxylates under 
our assay conditions (sodium KRP, pH 7.41, it does exhibit 
significant structural  and amino acid sequence homology with 
a recently described family of mammalian  Na+/glutamate 
cotransporters (17-19). Interestingly, Vadgama and  Chris- 
tensen 130) demonstrated  that System ASC does transport  an- 
ionic amino  acids  such as  cysteate  and cysteine sulfinate at pH 
<6. It will therefore be of interest  to  characterize  the pH de- 
pendence of the  transport properties of  SATT to  investigate  the 
functional basis for the  structural  and sequence similarity be- 
tween SATT and  the  mammalian  Na+/glutamate  cotransport- 
ers. 
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